A shocking revelation: Millions of Gen Zers are at risk due to low medical trial participation. But why is this happening? And what does it mean for the future of healthcare?
The Guardian's data analysis uncovers a concerning trend: Gen Z, born between the late 1990s and early 2000s, is largely missing from clinical trials and health studies. This is despite the fact that young adults aged 18 to 24 make up 8% of England's population. But they account for only 4.4% of medical research participants.
Here's where it gets controversial: Even though young adults may not be as affected by critical illnesses like cancer or heart disease, they still face a significant burden of various health conditions. Nearly half of those aged 24 or under live with long-term physical or mental health issues. Yet, their voices are not being heard in medical research.
Kirsty Blenkins, from the Association for Young People's Health, highlights the unique health challenges faced by this age group, often influenced by life transitions, social pressures, and inequalities. She warns that the lack of participation in research could lead to treatments and interventions being tailored primarily for older adults, potentially compromising safety and effectiveness for younger generations.
But why are Gen Zers not participating? Blenkins suggests several factors, including limited awareness of research opportunities, a lack of targeted recruitment, and concerns about confidentiality. She advocates for a more inclusive research design, engaging young people from the outset and ensuring their participation is accessible and meaningful.
The National Institute of Health and Care Research (NIHR) data further emphasizes this issue. From 2021 to 2024, only about seven young adults aged 18 to 24 participated in each of the 5,042 studies backed by the NIHR research delivery network. In contrast, older adults aged 85+ are overrepresented in research, despite making up a smaller percentage of the population.
Dr. Esther Mukuka from NIHR emphasizes the importance of Gen Z's involvement in health research, which goes beyond experimental treatments for serious illnesses. It shapes the management of everyday conditions and mental health support. She urges young people to participate, ensuring that future treatments cater to their unique needs.
The NIHR campaign encourages wider participation in health research, offering a volunteer registry to match individuals with relevant studies. This is a call to action for all, as anyone can participate, regardless of their health status. By contributing, individuals can help shape the future of healthcare.
But here's the twist: Dr. Wendy Macdowall reveals that women and ethnic minorities also face underrepresentation in research. She argues that understanding how different groups experience interventions is crucial to reducing inequities and ensuring fair and effective healthcare for all.
So, the question remains: How can we encourage more young people to participate in medical research? And how can we ensure that healthcare systems evolve to meet the diverse needs of Gen Z and beyond?
